93
patients
HNSCC
included
.

Sensitivity
specificity
brush
test
83
%
(
95
%
CI
:
67-92
%
)
85
%
(
95
%
CI
:
72-93
%
)
.

Results
p16
IHC
concordant
FFPE
samples
DNA
determinations
73/93
patients
.

In
53
patients
(
57
%
)
tumor
located
oropharynx
40
patients
(
43
%
)
tumor
located
non-oropharynx
region
.

Sensitivity
specificity
brush
test
patients
oropharyngeal
cancer
higher
86
%
(
95
%
CI
:
70-95
%
)
89
%
(
95
%
CI
:
65-99
%
)
.

